Archive

Rutgers & Posch advises Anders Invest on its acquisition of an equity stake in the Genap Group and the reinvestment by the current shareholders. The Genap Group is a Dutch concern that produces customised water storage systems and foil constructions for horticulture, agriculture, civil, road and hydraulic engineering. The Rutgers & Posch team consisted of Bas Mees, Laura Dingemans and Thomas Been.

Rutgers & Posch advises Anders Invest on its acquisition of an equity stake in the Falkom Group, the reinvestment by the seller, and the investment by a member of management. Falkom is a Dutch group that specialises in manufacturing customised recovery vehicles. The Rutgers & Posch team consisted of Bas Mees, Joost Kuipers and Manouk van Riele.

Rutgers & Posch advises Engius (a portfolio company of Green Park Investment Partners) on its acquisition of De Verenigde Expertise Groep and the reinvestment by the seller. De Verenigde Expertise Groep is a Dutch group that specialises in performing damage assessments, preliminary recordings, vibration measurements, deformation measurements and technical investigations. The Rutgers & Posch team consisted of Bas Mees, Joost Kuipers and Manouk van Riele.

Rutgers & Posch advises Anders Invest on the acquisition of an equity stake in Straatman Building Smart Connections and the reinvestment by the current shareholders. Straatman Building Smart Connections is a manufacturer of balcony railings and balustrades and has an annual turnover of €20 to €25 million and nearly 100 employees. Anders Invest is an investment fund that primarily invests for the long term in Dutch manufacturing companies,…

Rutgers & Posch advises its longstanding client Colbe (formerly known as Zorg van de Zaak), a portfolio company of Parcom, on the acquisition of Aquilum group, a specialist in sustainable employability. The transaction is still subject to approval by relevant regulatory authorities. The Rutgers & Posch team consisted of Matthijs van den Broek, Justus Fortuyn, Veerle Cordemeijer, Laura Dingemans, Jeanne Plettenburg, Hanna Steensma, Ilaha Muhseni and Maarten Minnaard.…

Rutgers & Posch represented NASDAQ listed uniQure N.V. in a public offering of 6,736,841 ordinary shares at a price of $47.50 per share, as well as pre-funded warrants to purchase 526,316 of its ordinary shares to certain investors. The gross proceeds to the company were approximately $345 million. uniQure is advancing a pipeline of proprietary gene therapies for the treatment of patients with Huntington’s disease, refractory temporal lobe…